Characterizing Safety Outcomes of a Dermal Filler: Injection Site and Timing Insights from the Maude Database
Perioral Volbella injections demonstrate increased vascular complication risks requiring modified clinical protocols: extended follow-up schedules (2-3 months versus standard 2 weeks), enhanced informed consent, and site-specific risk stratification. These findings provide immediate, actionable evidence for improving patient safety through evidence-based practice modifications.  .
Authors
- Yael Halaas (ORCID: https://orcid.org/0000-0001-6550-9316)
- Esther Auerbach
- Mark M. Shimanov
- Elana Eisenreich
- Shawnee Sebbag
- Daniel Yusupov
- David Musheyev
- Mark Spivak
- Eli Berglas
Publication Details
- Journal
- Journal of Drugs in Dermatology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.36849/jdd.9491
- Primary Topic
- Facial Rejuvenation and Surgery Techniques
- Type
- article
- Field-Weighted Citation Impact
- 0.00